Stockscreener 앱 받기
1.4388
5.96%
-0.0912
시간 외 거래:
1.43
-0.0088
-0.61%
전일 마감가:
$1.53
열려 있는:
$1.5
하루 거래량:
68,965
Relative Volume:
1.73
시가총액:
$4.79M
수익:
-
순이익/손실:
$-9.25M
주가수익비율:
-0.0665
EPS:
-21.6297
순현금흐름:
$-10.74M
1주 성능:
-13.65%
1개월 성능:
-8.94%
6개월 성능:
-58.89%
1년 성능:
-91.36%
1일 변동 폭
$1.3045
$1.50
1주일 범위
$1.3045
$1.7491
52주 변동 폭
$1.3045
$22.36
Silexion Therapeutics Corp Stock (SLXN) Company Profile
명칭
Silexion Therapeutics Corp
전화
972-8-6286005
주소
12 ABBA HILLEL ROAD, RAMAT GAN
Compare SLXN vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SLXN
Silexion Therapeutics Corp
|
1.4388 | 5.10M | 0 | -9.25M | -10.74M | -21.63 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Silexion Therapeutics Corp 주식(SLXN)의 최신 뉴스
Tangible book value per share of Silexion Therapeutics Corp – NASDAQ:SLXNW - TradingView
SLXNW Financials: Income Statement, Balance Sheet & Cash Flow | Silexion Therapeutics Corp - Stock Titan
Silexion Therapeutics Corp: Clinical-Stage KRAS Oncology Innovations and siRNA Pipeline for Pancreatic Cancer - Minichart
Silexion Therapeutics Reports 2025 Financial Results and Clinical Program Updates - geneonline.com
Biotech Silexion lines up 2026 pancreatic cancer trial after $18.6M cash raise - Stock Titan
Silexion Therapeutics 10-K: $11.9M net loss, cash $6.08M; operating loss $11.63M - TradingView
Silexion Therapeutics (NASDAQ: SLXN) outlines SIL204 KRAS cancer strategy in 10-K - Stock Titan
Silexion Therapeutics Corp Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Growth Recap: Is Silexion Therapeutics Corp Equity Warrant a potential multi baggerTrade Volume Report & Long-Term Capital Growth Ideas - baoquankhu1.vn
Setup Watch: Can Silexion Therapeutics Corp Equity Warrant stock outperform in a bear marketBreakout Watch & Entry Point Confirmation Signals - baoquankhu1.vn
SLXN SEC FilingsSilexion Therapeutics Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Analysts Are Bullish on Top Healthcare Stocks: MetaVia (MTVA), Immunome (IMNM) - The Globe and Mail
Fed Meeting: Can Silexion Therapeutics Corp Equity Warrant reach resistance levels soonQuarterly Profit Summary & Fast Gain Stock Trading Tips - baoquankhu1.vn
Silexion Therapeutics Urges Shareholders to Vote Ahead of March 16 Extraordinary General Meeting - Bitget
Silexion Therapeutics urges shareholders to vote ahead of EGM - TipRanks
Rally Mode: Is Silexion Therapeutics Corp a defensive stock2025 Price Targets & Entry and Exit Point Strategies - baoquankhu1.vn
SLXN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Book value per share of Silexion Therapeutics Corp – NASDAQ:SLXNW - TradingView
EPS Watch: Is First Light Acquisition Group Inc Equity Warrant vulnerable to short sellersQuarterly Portfolio Report & Smart Allocation Stock Tips - baoquankhu1.vn
SLXN Should I Buy - Intellectia AI
EBITDA per share of Silexion Therapeutics Corp – NASDAQ:SLXNW - TradingView
Market Fear: Should value investors consider CompoSecure Inc Equity WarrantMarket Activity Report & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Equity grants to director-linked fund at Silexion Therapeutics (SLXN) disclosed - Stock Titan
Director Alon Ruth receives Silexion (SLXN) share and stock option grants - Stock Titan
Silexion Therapeutics (SLXN) CFO receives 49,726-share equity grant - Stock Titan
Silexion (SLXN) CEO Hadar Ilan receives 64,350-share equity award - Stock Titan
Director at Silexion Therapeutics (SLXN) receives new share and option grants - Stock Titan
Silexion Therapeutics (SLXN) director granted 7,576 shares and 8,904 options - Stock Titan
Guangzhou Sino-Israel Biotech Fund gains SLXN equity for board service - Stock Titan
Ideas Watch: Is Olympic Steel Inc forming a breakout patternOptions Play & Weekly High Conviction Trade Ideas - baoquankhu1.vn
SLXNSilexion Therapeutics Corp Latest Stock News & Market Updates - Stock Titan
Will Silexion Therapeutics Corp benefit from geopolitical trendsDip Buying & AI Powered Buy/Sell Recommendations - mfd.ru
Can Silexion Therapeutics Corp Equity Warrant reach resistance levels soonWeekly Trend Recap & Expert Verified Movement Alerts - mfd.ru
Price Action: How volatile is Silexion Therapeutics Corp stockBull Run & Weekly Return Optimization Plans - baoquankhu1.vn
Silexion Therapeutics is developing a potential “holy grail” play in precision oncology (NASDAQ: SLXN) By FinanceWire - Investing.com
Silexion Therapeutics is developing a potential “holy grail” play in precision oncology (NASDAQ: SLXN) - TipRanks
Stock Report: Is Silexion Therapeutics Corp Equity Warrant stock forming a triangle patternWall Street Watch & Community Shared Stock Ideas - mfd.ru
Can Silexion Therapeutics Corp Equity Warrant stock deliver strong Q4 earningsQuarterly Portfolio Report & AI Enhanced Market Trend Forecasts - mfd.ru
S P Trends: Will CIMPRD benefit from rate cuts2025 Price Momentum & Daily Price Action Insights - baoquankhu1.vn
Momentum Shift: Should I hold or sell Silexion Therapeutics Corp now2025 Trading Volume Trends & Fast Gain Swing Alerts - baoquankhu1.vn
Can Silexion Therapeutics Corp sustain its profitability2025 Big Picture & Proven Capital Preservation Methods - mfd.ru
What’s the beta of Silexion Therapeutics Corp Equity Warrant stockJuly 2025 Highlights & Daily Risk Controlled Trade Plans - mfd.ru
Is Silexion Therapeutics Corp stock affected by interest rate hikesMarket Activity Recap & Fast Gain Stock Tips - mfd.ru
What’s the profit margin of Silexion Therapeutics CorpAnalyst Upgrade & Safe Entry Trade Reports - mfd.ru
Trading Recap: Will Silexion Therapeutics Corp Equity Warrant benefit from government policyQuarterly Trade Report & Short-Term High Return Strategies - baoquankhu1.vn
Analyst Downgrade: Can Silexion Therapeutics Corp be recession proofMarket Trend Summary & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Silexion Highlights SIL204 RNAi Pancreatic Cancer Program Progress - TipRanks
Silexion Therapeutics Corp Prepares Investor Presentation on SIL204 - TradingView
Jobs Data: What is ALBTs P E ratio telling us2025 Sector Review & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Swing Trade: What is the earnings history of Claritev Corporation2025 Big Picture & Fast Momentum Entry Tips - baoquankhu1.vn
Aug Opening: Will Silexion Therapeutics Corp Equity Warrant benefit from government policyQuarterly Profit Summary & Expert Approved Trade Ideas - baoquankhu1.vn
Silexion Therapeutics Corp (SLXN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):